Media
This second animation shows the first results of the ENDpoiNTs project and introduces the battery of novel testing methods.
Read MoreENDpoiNTs
Novel testing methods for endocrine disruption linked to developmental neurotoxicity
21/03/2022
26/08/2019
Our Research
To develop an integrated platform of in vivo, in vitro and in silico methods for testing chemicals for ED properties impacting on neurodevelopment.
Read MoreEvents
EURION Annual Cluster Meeting (5 Febr. 2020) and ENDpoiNTs Progress Meeting (6-7 Febr 2020)
Read MoreThe European project ENDpoiNTs will develop new testing and screening methods to identify endocrine disrupting chemicals (EDCs) that induce human developmental neurotoxicity (DNT). Clear evidence supports associations between endocrine disrupting chemical (EDC) exposure and impaired neurodevelopment. Yet, current hazard assessment of EDCs does not address developmental neurotoxicity. This is due to lack of scientific knowledge on how endocrine disruption is linked to developmental neurotoxicity (DNT). Thus there is an urgent need for novel testing and screening tools to address ED-induced DNT, based on new scientific knowledge.